GLP-1 receptor agonist
Semaglutide
A 31-residue analog of human GLP-1 (~94% sequence homology) with a C18 fatty-diacid chain attached via a linker — the modification drives reversible albumin binding and extended plasma half-life. The GLP-1 receptor agonist researchers reference by this name.
Read the full note →